According to Mirati Therapeutics's latest financial reports the company's current revenue (TTM) is HK$0.29 B. In 2022 the company made a revenue of HK$97.16 M a decrease over the revenue in the year 2021 that were of HK$0.56 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.